Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 1:10 AM
NCT ID:
NCT07257393
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥20;
2. PD diagnosis (MDS criteria);
3. On levodopa monotherapy with motor fluctuations;
4. Planned to start opicapone or safinamide;
5. Consent provided.
Exclusion Criteria:
1. Atypical/secondary parkinsonism;
2. Moderate-severe dementia;
3. DBS/MRgFUS/neurosurgery within 6 months;
4. Severe comorbidities limiting test
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT07257393
Study Brief:
Protocol Section:
NCT07257393